Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients.
作者信息
Cabanes Luis, Rubio Carla, Martinez Olalla, Naval Elsa
机构信息
Servicio Neumología, Hospital Universitario La Ribera, Alzira, Valencia, Spain.
Servicio de Microbiología, Hospital Universitario La Ribera, Alzira, Valencia, Spain.
出版信息
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):526-527. doi: 10.1016/j.eimce.2022.04.007. Epub 2022 May 7.
Abstract
摘要
相似文献
1
Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients.住院患者感染新冠病毒后每年的自然体液免疫情况。
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):526-527. doi: 10.1016/j.eimce.2022.04.007. Epub 2022 May 7.
2
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.评估针对 SARS-CoV-2 的体液免疫：蚀斑减少中和试验的验证和常规及替代中和测定法的多实验室比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17.
3
Getting to the (germinal) center of humoral immune responses to SARS-CoV-2.深入探究体液免疫应答 SARS-CoV-2 的（生发）中心。
Cell. 2022 Mar 17;185(6):945-948. doi: 10.1016/j.cell.2022.02.018.
4
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.在无症状至轻症 COVID-19 感染至少 8 个月后，仍能产生强大的体液和细胞免疫反应，并降低再次感染的风险。
J Intern Med. 2022 Jan;291(1):72-80. doi: 10.1111/joim.13387. Epub 2021 Sep 27.
5
Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.纵向免疫分析揭示了介导 COVID-19 恢复期个体长期体液免疫的优势表位。
J Allergy Clin Immunol. 2022 Apr;149(4):1225-1241. doi: 10.1016/j.jaci.2022.01.005. Epub 2022 Jan 21.
6
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者：体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
7
Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.动态描绘体液免疫对 SARS-CoV-2 的反应图谱，鉴定与重症 COVID-19 患者存活相关的非结构蛋白抗体。
Signal Transduct Target Ther. 2021 Aug 17;6(1):304. doi: 10.1038/s41392-021-00718-w.
8
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.多发性硬化症患者在接受奥瑞珠单抗和其他疾病修正治疗时对 SARS-CoV-2 感染的细胞和体液免疫：一项多民族观察性研究。
Ann Neurol. 2022 Jun;91(6):782-795. doi: 10.1002/ana.26346. Epub 2022 Apr 1.
9
Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?轻度至中度新型冠状病毒感染中随时间变化的不同体液免疫反应——病毒持续存在的迹象？
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.11.001. Epub 2021 Nov 6.
10
Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients.与接种疫苗的肾移植患者相比，新冠康复者的体液免疫反应
Transpl Int. 2022 Jan 18;35:10060. doi: 10.3389/ti.2021.10060. eCollection 2021.
本文引用的文献
1
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.SARS-CoV-2 感染可诱导人类骨髓浆细胞产生长期存活。
Nature. 2021 Jul;595(7867):421-425. doi: 10.1038/s41586-021-03647-4. Epub 2021 May 24.
2
Longitudinal dynamics of antibody responses in recovered COVID-19 patients.新冠康复患者抗体反应的纵向动态变化
Signal Transduct Target Ther. 2021 Mar 31;6(1):137. doi: 10.1038/s41392-021-00559-7.
3
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
4
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.医护人员中抗SARS-CoV-2抗体状态及感染发生率
N Engl J Med. 2021 Feb 11;384(6):533-540. doi: 10.1056/NEJMoa2034545. Epub 2020 Dec 23.
5
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.轻度 COVID-19 后，SARS-CoV-2 特异性免疫记忆仍具有功能性。
Cell. 2021 Jan 7;184(1):169-183.e17. doi: 10.1016/j.cell.2020.11.029. Epub 2020 Nov 23.
6
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.定义与疾病严重程度和结局相关的 SARS-CoV-2 感染后抗体反应的特征和持续时间。
Sci Immunol. 2020 Dec 7;5(54). doi: 10.1126/sciimmunol.abe0240.
7
Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.对 COVID-19 恢复期患者体内 SARS-CoV-2 抗体反应的特征描述。
J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10.
8
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.正交 SARS-CoV-2 血清学检测可用于监测低流行社区，并揭示持久的体液免疫。
Immunity. 2020 Nov 17;53(5):925-933.e4. doi: 10.1016/j.immuni.2020.10.004. Epub 2020 Oct 14.
9
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
10
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
Zotero 插件